Budget Impact of Etanercept Versus Adalimumab for Treatment of Rheumatoid Arthritis In Biologic-Naïve Patients in the United Kingdom
May 1, 2018, 00:00
10.1016/j.jval.2018.04.1317
https://www.valueinhealthjournal.com/article/S1098-3015(18)31620-6/fulltext
Title :
Budget Impact of Etanercept Versus Adalimumab for Treatment of Rheumatoid Arthritis In Biologic-Naïve Patients in the United Kingdom
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31620-6&doi=10.1016/j.jval.2018.04.1317
First page :
Section Title :
Open access? :
No
Section Order :
570